You are on page 1of 2

CLINICAL LABORATORY REPORT

NAME : Mr ARAVINDKUMAR OP/IP : OP/OP21-122450


UHID .NO : 12018066860 Requested On : 12/01/2022 12:41 PM
AGE / SEX : 29 Y 10 M 26 D /Male DOB : 15/02/1992 Collected On : 12/01/2022 08:29 PM
Ref. By : ER CARE GROUP Reported On : 12/01/2022 11:41 PM
INVESTIGATION TEST METHOD RESULT UNIT BIOLOGICAL REFERENCE INTERVAL
Molecular
SARS-COV-2
Swab

Test Name and Method :SARS-COV-2 REAL TIME PCR (Qualitative)


Specimen :NASAL SWAB/ORAL SWAB
Result:
SARS-COV-2 : POSITIVE

Comments:
A Negative result does not preclude SARS-CoV-2 and should not be used as the sole basis for patient management
decisions. In clinically suspected patients and those who had contact with a known positive patient, it is advisable to retest
in a fresh sample after 48 to 72 hours. (Clinical Sensitivity of the test is 60-80% )

A Positive result comes after thorough check of the controls , Each batch Validity ensured in addition to validating each Kit
prior to clinical diagnostic use . The analytical sensitivity of the assay is 95 % .Therefore , false positives are ruled out by all
means .

ICMR ID : 433829833

Note :
• ICMR Recommended kits are used for reporting . All the Positive cases will be notified to ICMR for further
Surveillance .

• Borderline positive cases (Ct Value > 30) may give variable results on repeat testing . The possible reasons could be
the variations in the kits and instruments used.

• Clinical correlation with patient history , radiology findings and co-infection with other viruses is essential for
individual case management . Ct values will not be shared in this test as it is a qualitative test and subjective to various
parameters . Ct values has no correlation with severity and has no implications on patient management .

Factors leading to false negative RT- PCR report :


• Inadequate specimen collection , poor quality of sample and non-representative sample .
• Sample collected too early or too late in the infection , improper sample handling and shipment .
• Technical reasons – PCR inhibitor , analytical sensitivity of kit used .
• Active recombination and / mutations in target genes used for detection of SARS-CoV- 2 virus .

Reference :
• Labcorp COVID-19 RT-PCR test EUA Summary / COVID -19 RT-PCR test (laboratory corporation of America).

** End of Report **

Ms Sharmila S DR. MUKUL VIJ, MD,PDCC DR. SUBHA S MD.,DNB


Sr.CONSULTANT PATHOLOGIST Consultant Microbiologist & Head
Result Entered / Verified By: Page 1 of 2 13-01-2022 12:01:27 AM
CLINICAL LABORATORY REPORT

Ms Sharmila S DR. MUKUL VIJ, MD,PDCC DR. SUBHA S MD.,DNB


Sr.CONSULTANT PATHOLOGIST Consultant Microbiologist & Head
Result Entered / Verified By: Page 2 of 2 13-01-2022 12:01:27 AM

You might also like